Absci (ABSI) Liabilities and Shareholders Equity (2020 - 2026)

Absci's (ABSI) quarterly Liabilities and Shareholders Equity came in at $195.6 million in Q1 2026, down 15.85% year-on-year from $232.4 million in Q1 2025, and down 9.57% quarter-over-quarter from $216.3 million in Q4 2025.

Absci (ABSI) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Absci has disclosed Liabilities and Shareholders Equity across 7 years of filings, most recently posting $195.6 million for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $195.6 million, down 15.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $866.8 million (down 7.48% YoY), and the FY2025 annual result was $216.3 million, up 1.26% from the prior year.
  • Liabilities and Shareholders Equity came in at $195.6 million for Q1 2026 at Absci, down from $216.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $395.5 million in Q1 2022 to a low of $195.6 million in Q1 2026.
  • The 5-year median for Liabilities and Shareholders Equity is $245.0 million (2025), against an average of $265.0 million.
  • Across the five-year window, Liabilities and Shareholders Equity soared 42.5% in 2022 and sank 32.31% in 2023, its largest moves.
  • Absci's Liabilities and Shareholders Equity stood at $321.0 million in 2022, then plunged by 32.31% to $217.3 million in 2023, then slipped by 1.7% to $213.6 million in 2024, then rose by 1.26% to $216.3 million in 2025, then dropped by 9.57% to $195.6 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $195.6 million (Q1 2026), $216.3 million (Q4 2025), and $245.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Absci 1.13 Bn 1.01 Bn - 195.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 195.59 Mn
Dec 31, 2025 216.30 Mn
Sep 30, 2025 244.99 Mn
Jun 30, 2025 209.89 Mn
Mar 31, 2025 232.45 Mn
Dec 31, 2024 213.61 Mn
Sep 30, 2024 235.23 Mn
Jun 30, 2024 255.53 Mn
Mar 31, 2024 274.90 Mn
Dec 31, 2023 217.30 Mn
Sep 30, 2023 236.34 Mn
Jun 30, 2023 254.15 Mn
Mar 31, 2023 295.81 Mn
Dec 31, 2022 321.01 Mn
Sep 30, 2022 339.39 Mn
Jun 30, 2022 366.32 Mn
Mar 31, 2022 395.46 Mn
Dec 31, 2021 426.20 Mn
Sep 30, 2021 449.12 Mn
Jun 30, 2021 257.07 Mn